Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

(2018) S. Claiborne Johnston et al.   NEW ENGLAND JOURNAL OF MEDICINE

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

(2018) William J. Powers et al.   STROKE

Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke

(2017) Xingyang Yi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic AttackClinical Perspective

(2016) Yuesong Pan et al.   CIRCULATION

Association BetweenCYP2C19Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack

(2016) Yilong Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke

(2016) Xingyang Yi et al.   Journal of Atherosclerosis and Thrombosis

Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population

(2016) Xingyang Yi et al.   JOURNAL OF NEUROLOGY

20-Hydroxyeicosatetraenoic Acid as a Predictor of Neurological Deterioration in Acute Minor Ischemic Stroke

(2016) Xingyang Yi et al.   STROKE

Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke

(2016) Xingyang Yi et al.   Therapeutic Advances in Neurological Disorders

Clopidogrel Plus Aspirin Prevents Early Neurologic Deterioration and Improves 6-Month Outcome in Patients With Acute Large Artery Atherosclerosis Stroke

(2014) Chun Wang et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

A Comparative Study of Dual versus Monoantiplatelet Therapy in Patients with Acute Large-Artery Atherosclerosis Stroke

(2014) Xingyang Yi et al.   Journal of Stroke & Cerebrovascular Diseases

Neurofluctuation in patients with subcortical ischemic stroke

(2014) F. S. Vahidy et al.   NEUROLOGY

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

(2014) Walter N. Kernan et al.   STROKE

Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

(2013) Yongjun Wang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Polymorphisms and Drug Interactions Leading to Clopidogrel Resistance: Why the Asian Population Requires Special Attention

(2012) Md. Shariful Hasan et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin non-responder status and early neurological deterioration: A prospective study

(2010) Jean-Marc Bugnicourt et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

(2008) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology

(2008) Norimichi Nakahata   PHARMACOLOGY & THERAPEUTICS